Coral Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "500.00",
    "chg": -3.75,
    "chgp": "-0.74%",
    "dir": -1,
    "prev_price": "503.75",
    "mcapval": "180.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE683E01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "147 ",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Coral Laboratories Ltd Upgraded to Sell on Improving Valuation Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-upgraded-to-sell-on-improving-valuation-despite-weak-financials-3953351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CoralLaboratori_mojoScore_3953351.png",
        "date": "2026-04-20 08:12:07",
        "description": "Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Apr 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical parameters. Despite ongoing challenges in profitability and sales growth, the company’s valuation and debt profile have improved sufficiently to warrant a less severe rating, though caution remains warranted given recent performance."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3941371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CoralLaboratori_mojoScore_3941371.png",
        "date": "2026-04-10 10:10:57",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3923691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_mojoScore_3923691.png",
        "date": "2026-03-30 10:10:44",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-falls-to-52-week-low-amid-continued-downtrend-3916024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3916024.png",
        "date": "2026-03-25 10:43:27",
        "description": ""
      }
    ],
    "total": 14,
    "sid": "476417",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annua Secretarial Compliance Report for the financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Cost Auditor",
      "datetime": "30-May-2026",
      "details": "Appointment of Cost Auditor",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 30 2026",
      "datetime": "30-May-2026",
      "details": "Outcome of Board meeting held on May 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Coral Laboratories Ltd Upgraded to Sell on Improving Valuation Despite Weak Financials

2026-04-20 08:12:07

Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Apr 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical parameters. Despite ongoing challenges in profitability and sales growth, the company’s valuation and debt profile have improved sufficiently to warrant a less severe rating, though caution remains warranted given recent performance.

Coral Laboratories Ltd is Rated Strong Sell

2026-04-10 10:10:57

Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Coral Laboratories Ltd is Rated Strong Sell

2026-03-30 10:10:44

Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low

2026-03-25 10:43:27

View All News